Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04292470 · ClinicalTrials.gov registry record · NA
Physiology of GERD and Treatment Response
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT04292470: Completed NA study, sponsored by University of California, Davis.
NCT04292470 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04292470, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study is designed to assess the physiologic and behavioral mechanisms associated with enhanced medication effects in adult patients with functional GERD-related symptoms.
Primary Outcome
Change in the average daily GERD symptom severity score over a 7-day period from baseline to the last week of the study in the expanded vs. standard group. GERD symptom severity is based on the sum of scores assessing the severity of daytime heartburn, nighttime heartburn, and acid reflux each on a 0-4 point scale (none, mild, moderate, severe, very severe; higher scores signify worse symptoms). Possible score range = 0 - 12. Change score calculated as average score at 8 weeks minus average scor
Interventions
- DRUG Amitriptyline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2020-11-05 |
| Est. Completion | 2021-11-04 |
| Phase | NA |
What the finished NCT04292470 record still lists
NCT04292470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Amitriptyline is the first listed.
NCT04292470 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04292470 about?
NCT04292470 is a clinical study titled "Physiology of GERD and Treatment Response". This study is designed to assess the physiologic and behavioral mechanisms associated with enhanced medication effects in adult patients with functional GERD-related symptoms.
What is the current status of trial NCT04292470?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2020-11-05. Estimated completion is 2021-11-04.
What interventions are being tested in trial NCT04292470?
The interventions under investigation include: Amitriptyline (DRUG).
Who is sponsoring clinical trial NCT04292470?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04292470's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI